Report Detail
Global Mantle Cell Lymphoma Treatment Market Professional Survey Report 2019
- RnM2840975 |
- 30 January, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
The global Mantle Cell Lymphoma Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Mantle Cell Lymphoma Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mantle Cell Lymphoma Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Mantle Cell Lymphoma Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Mantle Cell Lymphoma Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Astex Pharmaceuticals, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cellular Biomedicine Group, Inc.
Eisai
EpiZyme, Inc.
Fate Therapeutics, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
ImmunoGen, Inc.
Immunomedics, Inc.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Acalabrutinib
JCAR-017
JNJ-64052781
Acalisib
IGN-002
IMGN-529
AFM-11
Others
Segment by Application
Hospital
Clinic
Others
Table of Contents
Executive Summary
1 Industry Overview of Mantle Cell Lymphoma Treatment
- 1.1 Definition of Mantle Cell Lymphoma Treatment
- 1.2 Mantle Cell Lymphoma Treatment Segment by Type
- 1.2.1 Global Mantle Cell Lymphoma Treatment Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Acalabrutinib
- 1.2.3 JCAR-017
- 1.2.4 JNJ-64052781
- 1.2.5 Acalisib
- 1.2.6 IGN-002
- 1.2.7 IMGN-529
- 1.2.8 AFM-11
- 1.2.9 Others
- 1.3 Mantle Cell Lymphoma Treatment Segment by Applications
- 1.3.1 Global Mantle Cell Lymphoma Treatment Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Global Mantle Cell Lymphoma Treatment Overall Market
- 1.4.1 Global Mantle Cell Lymphoma Treatment Revenue (2014-2025)
- 1.4.2 Global Mantle Cell Lymphoma Treatment Production (2014-2025)
- 1.4.3 North America Mantle Cell Lymphoma Treatment Status and Prospect (2014-2025)
- 1.4.4 Europe Mantle Cell Lymphoma Treatment Status and Prospect (2014-2025)
- 1.4.5 China Mantle Cell Lymphoma Treatment Status and Prospect (2014-2025)
- 1.4.6 Japan Mantle Cell Lymphoma Treatment Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Mantle Cell Lymphoma Treatment Status and Prospect (2014-2025)
- 1.4.8 India Mantle Cell Lymphoma Treatment Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Mantle Cell Lymphoma Treatment
- 2.3 Manufacturing Process Analysis of Mantle Cell Lymphoma Treatment
- 2.4 Industry Chain Structure of Mantle Cell Lymphoma Treatment
3 Development and Manufacturing Plants Analysis of Mantle Cell Lymphoma Treatment
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Mantle Cell Lymphoma Treatment Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Mantle Cell Lymphoma Treatment
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Mantle Cell Lymphoma Treatment Production and Capacity Analysis
- 4.2 Mantle Cell Lymphoma Treatment Revenue Analysis
- 4.3 Mantle Cell Lymphoma Treatment Price Analysis
- 4.4 Market Concentration Degree
5 Mantle Cell Lymphoma Treatment Regional Market Analysis
- 5.1 Mantle Cell Lymphoma Treatment Production by Regions
- 5.1.1 Global Mantle Cell Lymphoma Treatment Production by Regions
- 5.1.2 Global Mantle Cell Lymphoma Treatment Revenue by Regions
- 5.2 Mantle Cell Lymphoma Treatment Consumption by Regions
- 5.3 North America Mantle Cell Lymphoma Treatment Market Analysis
- 5.3.1 North America Mantle Cell Lymphoma Treatment Production
- 5.3.2 North America Mantle Cell Lymphoma Treatment Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Mantle Cell Lymphoma Treatment Import and Export
- 5.4 Europe Mantle Cell Lymphoma Treatment Market Analysis
- 5.4.1 Europe Mantle Cell Lymphoma Treatment Production
- 5.4.2 Europe Mantle Cell Lymphoma Treatment Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Mantle Cell Lymphoma Treatment Import and Export
- 5.5 China Mantle Cell Lymphoma Treatment Market Analysis
- 5.5.1 China Mantle Cell Lymphoma Treatment Production
- 5.5.2 China Mantle Cell Lymphoma Treatment Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Mantle Cell Lymphoma Treatment Import and Export
- 5.6 Japan Mantle Cell Lymphoma Treatment Market Analysis
- 5.6.1 Japan Mantle Cell Lymphoma Treatment Production
- 5.6.2 Japan Mantle Cell Lymphoma Treatment Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Mantle Cell Lymphoma Treatment Import and Export
- 5.7 Southeast Asia Mantle Cell Lymphoma Treatment Market Analysis
- 5.7.1 Southeast Asia Mantle Cell Lymphoma Treatment Production
- 5.7.2 Southeast Asia Mantle Cell Lymphoma Treatment Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Mantle Cell Lymphoma Treatment Import and Export
- 5.8 India Mantle Cell Lymphoma Treatment Market Analysis
- 5.8.1 India Mantle Cell Lymphoma Treatment Production
- 5.8.2 India Mantle Cell Lymphoma Treatment Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Mantle Cell Lymphoma Treatment Import and Export
6 Mantle Cell Lymphoma Treatment Segment Market Analysis (by Type)
- 6.1 Global Mantle Cell Lymphoma Treatment Production by Type
- 6.2 Global Mantle Cell Lymphoma Treatment Revenue by Type
- 6.3 Mantle Cell Lymphoma Treatment Price by Type
7 Mantle Cell Lymphoma Treatment Segment Market Analysis (by Application)
- 7.1 Global Mantle Cell Lymphoma Treatment Consumption by Application
- 7.2 Global Mantle Cell Lymphoma Treatment Consumption Market Share by Application (2014-2019)
8 Mantle Cell Lymphoma Treatment Major Manufacturers Analysis
- 8.1 Astex Pharmaceuticals, Inc.
- 8.1.1 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
- 8.1.2 Astex Pharmaceuticals, Inc. Product Introduction, Application and Specification
- 8.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Bayer AG
- 8.2.1 Bayer AG Mantle Cell Lymphoma Treatment Production Sites and Area Served
- 8.2.2 Bayer AG Product Introduction, Application and Specification
- 8.2.3 Bayer AG Mantle Cell Lymphoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Bristol-Myers Squibb Company
- 8.3.1 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Production Sites and Area Served
- 8.3.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
- 8.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Celgene Corporation
- 8.4.1 Celgene Corporation Mantle Cell Lymphoma Treatment Production Sites and Area Served
- 8.4.2 Celgene Corporation Product Introduction, Application and Specification
- 8.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Cellular Biomedicine Group, Inc.
- 8.5.1 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
- 8.5.2 Cellular Biomedicine Group, Inc. Product Introduction, Application and Specification
- 8.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Eisai
- 8.6.1 Eisai Mantle Cell Lymphoma Treatment Production Sites and Area Served
- 8.6.2 Eisai Product Introduction, Application and Specification
- 8.6.3 Eisai Mantle Cell Lymphoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 EpiZyme, Inc.
- 8.7.1 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
- 8.7.2 EpiZyme, Inc. Product Introduction, Application and Specification
- 8.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Fate Therapeutics, Inc.
- 8.8.1 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
- 8.8.2 Fate Therapeutics, Inc. Product Introduction, Application and Specification
- 8.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Genentech, Inc.
- 8.9.1 Genentech, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
- 8.9.2 Genentech, Inc. Product Introduction, Application and Specification
- 8.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Gilead Sciences, Inc.
- 8.10.1 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
- 8.10.2 Gilead Sciences, Inc. Product Introduction, Application and Specification
- 8.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 GlaxoSmithKline Plc
- 8.12 Hutchison MediPharma Limited
- 8.13 ImmunoGen, Inc.
- 8.14 Immunomedics, Inc.
9 Development Trend of Analysis of Mantle Cell Lymphoma Treatment Market
- 9.1 Global Mantle Cell Lymphoma Treatment Market Trend Analysis
- 9.1.1 Global Mantle Cell Lymphoma Treatment Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Mantle Cell Lymphoma Treatment Regional Market Trend
- 9.2.1 North America Mantle Cell Lymphoma Treatment Forecast 2019-2025
- 9.2.2 Europe Mantle Cell Lymphoma Treatment Forecast 2019-2025
- 9.2.3 China Mantle Cell Lymphoma Treatment Forecast 2019-2025
- 9.2.4 Japan Mantle Cell Lymphoma Treatment Forecast 2019-2025
- 9.2.5 Southeast Asia Mantle Cell Lymphoma Treatment Forecast 2019-2025
- 9.2.6 India Mantle Cell Lymphoma Treatment Forecast 2019-2025
- 9.3 Mantle Cell Lymphoma Treatment Market Trend (Product Type)
- 9.4 Mantle Cell Lymphoma Treatment Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Mantle Cell Lymphoma Treatment Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Mantle Cell Lymphoma Treatment . Industry analysis & Market Report on Mantle Cell Lymphoma Treatment is a syndicated market report, published as Global Mantle Cell Lymphoma Treatment Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Mantle Cell Lymphoma Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
